HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.

Abstract
Tiazofurin, an anti-cancer drug, which induces remissions in human leukemia, and ribavirin, an anti-viral agent, bind at separate sites (NADH and IMP-XMP sites, respectively) on the target enzyme, IMP dehydrogenase. Now we show that the binding to IMP dehydrogenase of these drugs at two separate sites is translated into synergistic inhibition of de novo guanylate biosynthesis and synergistic toxicity in rat hepatoma 3924A cells. These results may be utilized in the chemotherapy of neoplastic diseases and in the treatment of hepatitis virus infection and hepatocellular carcinoma.
AuthorsY Natsumeda, Y Yamada, Y Yamaji, G Weber
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 153 Issue 1 Pg. 321-7 (May 31 1988) ISSN: 0006-291X [Print] United States
PMID2897852 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Organoselenium Compounds
  • Purines
  • Ribonucleosides
  • Ribavirin
  • Guanosine Monophosphate
  • IMP Dehydrogenase
  • Selenium
  • selenazofurin
  • tiazofurin
Topics
  • Animals
  • Cell Line
  • Cell Survival (drug effects)
  • Drug Synergism
  • Guanosine Monophosphate (biosynthesis)
  • IMP Dehydrogenase (metabolism)
  • Liver Neoplasms, Experimental (pathology)
  • Organoselenium Compounds
  • Purines (biosynthesis)
  • Rats
  • Ribavirin (analogs & derivatives, pharmacology)
  • Ribonucleosides (pharmacology)
  • Selenium (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: